23 February 2018 - - Boston, Massachusetts-based human biology specialist Emulate, Inc. has formed a strategic partnership with Basel, Switzerland-based biotech company Roche (SIX: RO) (OTCQX: RHHBY) that will use Emulate's Human Emulation Syste...
23 February 2018 - - Scientists at Los Angeles, California-based healthcare specialist Cedars-Sinai and Boston, Massachusetts-based human biology specialist Emulate, Inc. are pioneering a Patient-on-a-Chip program to help predict which disease treatm...
23 February 2018 - - The US Food and Drug Administration has accepted US-based biopharmaceutical company Acorda Therapeutics, Inc.'s (NASDAQ: ACOR) new drug application (NDA) for Inbrija, an investigational inhaled levodopa treatment for symptom...
23 February 2018 - - Boulder, Colorado-based clinical-stage medical dermatology company Brickell Biotech, Inc. has presented positive confirmatory Phase 2b study (CL-203) results with sofpironium bromide for the topical treatment of primary axillary ...
23 February 2018 - Global health care company Novo Nordisk A/S (CPH:NOVOB) announced on Thursday headline results from PIONEER 1, the first phase 3a trial with oral semaglutide for treatment of adults with type 2 diabetes.Oral semaglutide is a new GL...